|
1
|
Jalkh N, Nassar-Slaba J, Chouery E, Salem
N, Uhrchammer N, Golmard L, Stoppa-Lyonnet D, Bignon YJ and
Mégarbané A: Prevalance of BRCA1 and BRCA2 mutations in familial
breast cancer patients in Lebanon. Hered Cancer Clin Pract.
10:72012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Coughlin SS and Ekwueme DU: Breast cancer
as a global health concern. Cancer Epidemiol. 33:315–318. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Benson JR, Jatoi I, Keisch M, Esteva FJ,
Makris A and Jordan VC: Early breast cancer. Lancet. 373:1463–1479.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Lv W, Chen N, Lin Y, Ma H, Ruan Y, Li Z,
Li X, Pan X and Tian X: Macrophage migration inhibitory factor
promotes breast cancer metastasis via activation of HMGB1/TLR4/NF
kappa B axis. Cancer Lett. 375:245–255. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Ghislain I, Zikos E, Coens C, Quinten C,
Balta V, Tryfonidis K, Piccart M, Zardavas D, Nagele E,
Bjelic-Radisic V, et al: Health-related quality of life in locally
advanced and metastatic breast cancer: Methodological and clinical
issues in randomised controlled trials. Lancet Oncol. 17:e294–e304.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luo J, Yao JF, Deng XF, Zheng XD, Jia M,
Wang YQ, Huang Y and Zhu JH: 14, 15-EET induces breast cancer cell
EMT and cisplatin resistance by up-regulating integrin αvβ3 and
activating FAK/PI3K/AKT signaling. J Exp Clin Cancer Res.
37:232018. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sun L, Yao Y, Liu B, Lin Z, Lin L, Yang M,
Zhang W, Chen W, Pan C, Liu Q, et al: MiR-200b and miR-15b regulate
chemotherapy-induced epithelial-mesenchymal transition in human
tongue cancer cells by targeting BMI1. Oncogene. 31:432–445. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan
A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al: The
epithelial-mesenchymal transition generates cells with properties
of stem cells. Cell. 133:704–715. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
DiMeo TA, Anderson K, Phadke P, Fan C,
Perou CM, Naber S and Kuperwasser C: A novel lung metastasis
signature links Wnt signaling with cancer cell self-renewal and
epithelial-mesenchymal transition in basal-like breast cancer.
Cancer Res. 69:5364–5373. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Nuylan M, Kawano T, Inazawa J and Inoue J:
Down-regulation of LAPTM5 in human cancer cells. Oncotarget.
7:28320–28328. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Li X, Su Y, Zhang J, Zhu Y, Xu Y and Wu G:
LAPTM5 plays a Key role in the diagnosis and prognosis of
testicular germ cell tumors. Int J Genomics. 2021:88164562021.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Chen L, Wang G, Luo Y, Wang Y, Xie C,
Jiang W, Xiao Y, Qian G and Wang X: Downregulation of LAPTM5
suppresses cell proliferation and viability inducing cell cycle
arrest at G0/G1 phase of bladder cancer cells. Int J Oncol.
50:263–271. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Sui Y, Lu K and Fu L: Prediction and
analysis of novel key genes ITGAX, LAPTM5, SERPINE1 in clear cell
renal cell carcinoma through bioinformatics analysis. PeerJ.
9:e112722021. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Brunkow ME, Jeffery EW, Hjerrild KA,
Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF
and Ramsdell F: Disruption of a new forkhead/winged-helix protein,
scurfin, results in the fatal lymphoproliferative disorder of the
scurfy mouse. Nat Genet. 27:68–73. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Szylberg Ł, Karbownik D and Marszałek A:
The role of FOXP3 in human cancers. Anticancer Res. 36:3789–3794.
2016.PubMed/NCBI
|
|
16
|
Zhang C, Xu Y, Hao Q, Wang S, Li H, Li J,
Gao Y, Li M, Li W, Xue X, et al: FOXP3 suppresses breast cancer
metastasis through downregulation of CD44. Int J Cancer.
137:1279–1290. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zuo T, Wang L, Morrison C, Chang X, Zhang
H, Li W, Liu Y, Wang Y, Liu X, Chan MWY, et al: FOXP3 is an
X-linked breast cancer suppressor gene and an important repressor
of the HER-2/ErbB2 oncogene. Cell. 129:1275–1286. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Douglass S, Ali S, Meeson AP, Browell D
and Kirby JA: The role of FOXP3 in the development and metastatic
spread of breast cancer. Cancer Metastasis Rev. 31:843–854. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Ladoire S, Mignot G, Dalban C, Chevriaux
A, Arnould L, Rébé C, Apetoh L, Boidot R, Penault-Llorca F,
Fumoleau P, et al: FOXP3 expression in cancer cells and
anthracyclines efficacy in patients with primary breast cancer
treated with adjuvant chemotherapy in the phase III UNICANCER-PACS
01 trial. Ann Oncol. 23:2552–2561. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Bahrami A, Hasanzadeh M, ShahidSales S,
Yousefi Z, Kadkhodayan S, Farazestanian M, Joudi Mashhad M, Gharib
M, Mahdi Hassanian S and Avan A: Clinical significance and
prognosis value of Wnt signaling pathway in cervical cancer. J Cell
Biochem. 118:3028–3033. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Liu J and Wang Y: Long non-coding RNA
KCNQ1OT1 facilitates the progression of cervical cancer and tumor
growth through modulating miR-296-5p/HYOU1 axis. Bioengineered.
12:8753–8767. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Clevers H and Nusse R: Wnt/β-catenin
signaling and disease. Cell. 149:1192–1205. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kypta RM and Waxman J: Wnt/β-catenin
signalling in prostate cancer. Nat Rev Urol. 9:418–428. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Wang Z, Li B, Zhou L, Yu S, Su Z, Song J,
Sun Q, Sha O, Wang X, Jiang W, et al: Prodigiosin inhibits
Wnt/β-catenin signaling and exerts anticancer activity in breast
cancer cells. Proc Natl Acad Sci USA. 113:13150–13155. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Li Y, Jin K, van Pelt GW, van Dam H, Yu X,
Mesker WE, Ten Dijke P, Zhou F and Zhang L: c-Myb enhances breast
cancer invasion and metastasis through the Wnt/β-catenin/Axin2
pathway. Cancer Res. 76:3364–3375. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Dey N, Barwick BG, Moreno CS,
Ordanic-Kodani M, Chen Z, Oprea-Ilies G, Tang W, Catzavelos C,
Kerstann KF, Sledge GW Jr, et al: Wnt signaling in triple negative
breast cancer is associated with metastasis. BMC Cancer.
13:5372013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Jézéquel P, Gouraud W, Ben Azzouz F,
Guérin-Charbonnel C, Juin PP, Lasla H and Campone M: bc-GenExMiner
4.5: New mining module computes breast cancer differential gene
expression analyses. Database (Oxford). 2021:baab0072021.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Lánczky A and Győrffy B: Web-based
survival analysis tool tailored for medical research (KMplot):
Development and implementation. J Med Internet Res. 23:e276332021.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Amat S, Penault-Llorca F, Cure H, Le
Bouedëc G, Achard JL, Van Praagh I, Feillel V, Mouret-Reynier MA,
Dauplat J and Chollet P: Scarff-bloom-richardson (SBR) grading: A
pleiotropic marker of chemosensitivity in invasive ductal breast
carcinomas treated by neoadjuvant chemotherapy. Int J Oncol.
20:791–796. 2002.PubMed/NCBI
|
|
31
|
Corso G, Figueiredo J, De Angelis SP,
Corso F, Girardi A, Pereira J, Seruca R, Bonanni B, Carneiro P,
Pravettoni G, et al: E-cadherin deregulation in breast cancer. J
Cell Mol Med. 24:5930–5936. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Thiery JP, Acloque H, Huang RYJ and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Xiao M, Jia S, Wang H, Wang J, Huang Y and
Li Z: Overexpression of LAPTM4B: An independent prognostic marker
in breast cancer. J Cancer Res Clin Oncol. 139:661–667. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Meng Q, Zhou L, Liang H, Hu A, Zhou H,
Zhou J, Zhou X, Lin H, Li X, Jiang L and Dong J: Spine-specific
downregulation of LAPTM5 expression promotes the progression and
spinal metastasis of estrogen receptor-positive breast cancer by
activating glutamine-dependent mTOR signaling. Int J Oncol.
60:472022. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Hosooka T and Ogawa W: A novel role for
the cell cycle regulatory complex cyclin D1-CDK4 in
gluconeogenesis. J Diabetes Investig. 7:27–28. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Malumbres M and Barbacid M: Mammalian
cyclin-dependent kinases. Trends Biochem Sci. 30:630–641. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Nishisho I, Nakamura Y, Miyoshi Y, Miki Y,
Ando H, Horii A, Koyama K, Utsunomiya J, Baba S and Hedge P:
Mutations of chromosome 5q21 genes in FAP and colorectal cancer
patients. Science. 253:665–669. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Yang M, Wang M, Li X, Xie Y, Xia X, Tian
J, Zhang K and Tang A: Wnt signaling in cervical cancer? J Cancer.
9:1277–1286. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Peifer M, McCrea PD, Green KJ, Wieschaus E
and Gumbiner BM: The vertebrate adhesive junction proteins
beta-catenin and plakoglobin and the Drosophila segment polarity
gene armadillo form a multigene family with similar properties. J
Cell Biol. 118:681–691. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Gao Y and Chen Z, Wang R, Tan X, Huang C,
Chen G and Chen Z: LXRα promotes the differentiation of human
gastric cancer cells through inactivation of Wnt/β-catenin
signaling. J Cancer. 10:156–167. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yeh Y, Guo Q, Connelly Z, Cheng S, Yang S,
Prieto-Dominguez N and Yu X: Wnt/beta-catenin signaling and
prostate cancer therapy resistance. Adv Exp Med Biol. 1210:351–378.
2019. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Peng N, Zhang Z, Wang Y, Yang M, Fan J,
Wang Q, Deng L, Chen D, Cai Y, Li Q, et al: Down-regulated
LINC00115 inhibits prostate cancer cell proliferation and invasion
via targeting miR-212-5p/FZD5/Wnt/β-catenin axis. J Cell Mol Med.
25:10627–10637. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Gong Z, Jia H, Yu J, Liu Y, Ren J, Yang S,
Hu B, Liu L, Lai PBS and Chen GG: Nuclear FOXP3 inhibits tumor
growth and induced apoptosis in hepatocellular carcinoma by
targeting c-Myc. Oncogenesis. 9:972020. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Liu C, Han J, Li X, Huang T, Gao Y, Wang
B, Zhang K, Wang S, Zhang W, Li W, et al: FOXP3 inhibits the
metastasis of breast cancer by downregulating the expression of
MTA1. Front Oncol. 11:6561902021. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang L, Liu R, Li W, Chen C, Katoh H, Chen
GY, McNally B, Lin L, Zhou P, Zuo T, et al: Somatic single hits
inactivate the X-linked tumor suppressor FOXP3 in the prostate.
Cancer Cell. 16:336–346. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Zuo T, Liu R, Zhang H, Chang X and Liu Y,
Wang L, Zheng P and Liu Y: FOXP3 is a novel transcriptional
repressor for the breast cancer oncogene SKP2. J Clin Invest.
117:3765–3773. 2007.PubMed/NCBI
|
|
47
|
Huang Z, Liu F, Wang W, Ouyang S, Sang T,
Huang Z, Liao L and Wu J: Deregulation of circ_003912 contributes
to pathogenesis of erosive oral lichen planus by via sponging
microRNA-123, −647 and −31 and upregulating FOXP3. Mol Med.
27:1322021. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Douglass S, Meeson AP, Overbeck-Zubrzycka
D, Brain JG, Bennett MR, Lamb CA, Lennard TW, Browell D, Ali S and
Kirby JA: Breast cancer metastasis: Demonstration that FOXP3
regulates CXCR4 expression and the response to CXCL12. J Pathol.
234:74–85. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
McInnes N, Sadlon TJ, Brown CY, Pederson
S, Beyer M, Schultze JL, McColl S, Goodall GJ and Barry SC: FOXP3
and FOXP3-regulated microRNAs suppress SATB1 in breast cancer
cells. Oncogene. 31:1045–1054. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Hilton HN, Clarke CL and Graham JD:
Estrogen and progesterone signalling in the normal breast and its
implications for cancer development. Mol Cell Endocrinol. 466:2–14.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Russo J and Russo IH: Development of the
human breast. Maturitas. 49:2–15. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Yin L, Duan JJ, Bian XW and Yu SC:
Triple-negative breast cancer molecular subtyping and treatment
progress. Breast Cancer Res. 22:612020. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Borri F and Granaglia A: Pathology of
triple negative breast cancer. Semin Cancer Biol. 72:136–145. 2021.
View Article : Google Scholar : PubMed/NCBI
|
